PALISADE BIO, INC. — Director's Dealing 2015

May 29, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2015-05-22

Reporting Person: OGILVIE SCOTT VARDE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-05-22	Common Stock	M	60000	$1.32	Acquired	80837	Direct
2015-05-22	Common Stock	F	48293	$1.64	Disposed	32544	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-05-22	Common Stock purchase option	$1.32	M	60000	Disposed	2015-05-28	Common Stock (60000)	Direct

Footnotes

F1: Represents 48,293 shares withheld by the Issuer at the market price of $1.64 per share less an exercise price of $1.32 per share to fund the cashless exercise of 60,000 options. The total number of shares issued to Reporting Person pursuant to the cashless exercise of the options is 11,707.

F2: Represents options issued pursuant to Issuer's 2007 Equity Compensation Plan and in compliance with its non-executive director compensation plan. The option was exercised on a cashless basis on 5/22/2015.